Alchemab Therapeutics raised €29M in a Series A round in Jul 2026. The company is based in London, UK. Investors in the round: British Business Bank. Data as of 9 Jul 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
